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Infertility Can Affect Anyone 
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Infertility is a Disease 
 Infertility is more than a quality-of-life issue 
 
 Infertility is considered a disease of the reproductive system 
according to  
 
 World Health Organization (WHO) in 2009 
 
 American Society for Reproductive Medicine (ASRM) in 2013 
 
 Zegers-Hochschild F, Fertil Steril 2009. 




Reproduction is a Major Life Activity 
 
ADA: Americans with Disabilities Act  
Bragdon v Abbott, 524 US 624 (1998). 
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 Disparities in access to care and treatment 
 
More infants born from use of infertility treatments 
 ~ 6% infants from ovarian stimulation treatments 
 1.5% infants from assisted reproductive technologies (ART) 
 
 Long-term outcomes of treatment are unknown 
Infertility is a Public Health Concern 
Intrauterine insemination 
Schieve, Am J Epidemiol 2009.  
Ovulation medications  In vitro fertilization 
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Infertility is a Marker of Past,  
Present, and Future Health 
                                                                                                                                      
  
Walsh, Cancer 2010.    
Eisenberg, Hum Reprod 2014.    
Honig, Fertil Steril 1994. 
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Many Factors Contributing to Infertility  
Can Be Prevented 
Infectious Diseases Environmental and  
Workplace Exposures 
        Genetic and 
     Physical Abnormalities 
 Sexually transmitted infections can lead to pelvic inflammatory 
disease (PID) and tubal factor infertility (TFI) 
 TFI accounts for 10%–40% of infertility  
 About 30% of PID is associated with gonorrhea and chlamydia 
 
 Environmental and workplace exposures can affect sperm quality 











Jain, Fertil Steril 2006. Sharara Fertil Steril 2000. 
Hillier, CDC STD Prevention Science Series 2013. 
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Many Factors Contributing to Infertility  
Can be Prevented 




 Certain medications (e.g., chemotherapy) can result in infertility  
 Fertility preservation methods should be considered 
  













       -induced 
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Hurdles in Defining Infertility 
 Varying case definitions used across settings and populations 
 Reproductive outcome (e.g., absence of pregnancy or live birth) 
 Length of time without conception (e.g., 1, 2, or 5 years) 
 Type of infertility (e.g., primary or secondary) 
 
 Clinical definitions 
 Infertility — Inability to conceive after 12 months of trying  
 Impaired fecundity — Difficulty getting pregnant or carrying a 






Gurunath, Human Reprod Update 2011. 
Practice Committee of the American Society for Reproductive Medicine, Fertil Steril Jan 2013. 
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Infertility Affects Both Women and Men 
 Couple-based impairment affecting males and females 
 Female   33% 
 Male   20% 
 Mixed    39% 
 Unexplained           8% 
 
 U.S. National Survey of Family Growth, 2006–2010 
 Women (married) 
 Infertility     6% 
 Impaired fecundity   12% 
 Men 
 Infertility    9% 
 
Thonneau P, Hum Reprod 1991.  
Chandra A, National Health Statistics Reports; no 67, 2013.  
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Impaired Fecundity Increases with Age 






























































White Paper and National Action Plan for Detection, 
Prevention and Management of Infertility 
                                                                    
Macaluso, Fertil Steril 2010. 
Centers for Disease Control and Prevention. National Public Health Action Plan for the Detection, Prevention, and Management of Infertility, July 2014. 
Available at  http://www.cdc.gov/reproductivehealth/Infertility/PublicHealth.htm 
Published July 2014 
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Improving the Outcome of Infertility Therapy 
A Clinical Perspective 
Eli Y. Adashi, MD, MS, CPE, FACOG 
Professor of Medical Science 
The Warren Alpert Medical School 
Division of Biology and Medicine 
Brown University 
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Goal of Infertility Therapy 
The BESST Outcome is a… 
 
Birth Emphasizing a  
Successful 





Min JA, Human Reprod 2004. 
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 Advice 29 
 Infertility Testing 27 
Non-ART 
Ovulation-Inducing Drugs 20 
Artificial Insemination 7 
Surgery 3.4 
           ART                                          IVF                      3.1 
ART: Assisted  Reproductive Technology 
IVF: In vitro fertilization  
Infertility Service Use in the United States: National Health Statistics Report; no 73, 2014. 
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Controlled Ovarian Stimulation  
with Timed Intrauterine Insemination (IUI) 
 





Stimulation Timed IUI (within 48 hours) Ovulation 
 Available in the U.S. since 1987 
 
 Indicated for women diagnosed with Unexplained 
Ovulatory Subfertility 
hCG: Human chorionic gonadotropin 
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Oocytes IVF Embryo Transfer 
Stimulation Ovulation Retrieval Fertilization Transfer 
 Available at approximately 500 clinical sites 
 
 Indicated for  
 Anatomic Pathology 
 Male Factor 
 Age-related Infertility 
 Unexplained Ovulatory Subfertility 
hCG: Human chorionic gonadotropin 
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A Brief History of IVF 
 Actualized in the UK in 1978 
 Introduced into the US in 1981  
 Over 5 million babies born worldwide 
as a result of IVF 
Louise Brown, the world's first "test tube baby" 
with her mother Lesley.  
Photo taken 9 October, 1978. 
Photo: Brian Bould / Daily Mail / Rex Features /IBL Bildbyrå 
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The 2010 Nobel Prize  
In Physiology or Medicine  
Professor Robert Edwards at his desk at Bourn Hall Clinic, England.  
Photo taken in 1989. Nobel Prize “for the development of in vitro fertilization” 
CORBIN O'GRADY STUDIO/ Science Photo Library / IBL Bildbyrå 
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ART: Assisted Reproductive Technology 




Triplet or higher order 
Both treatments increase the incidence of multiple births, 
 thereby increasing maternal morbidity and mortality 
22 
The Maternal Burden of Plurality 
Practice Committee of American Society for Reproductive Medicine, Fertil Steril April 2012. 
Complication Singleton Twin Triplet Quadruplet 
Preeclampsia 6 10-12 25-60 >60 
Gestational diabetes 3 5-8 7 >10 
Preterm birth 15 40 75 >95 
Delivery <37 weeks 10 50 92 >95 
Delivery <32 weeks 2 8 26 >95 
Incidence (%) of major maternal complications in pregnancy 
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Outcome Singleton Twin Triplet 
Average Gestational Age (weeks) 39.1 35.3 32.2 
Average Birth Weight (gm) 3,358 2,347 1,687 
Average Birth Weight 7 lbs 8 oz 5 lbs 4 oz 3 lbs 12 oz 
Fetal Death (%) .03 .09 .14 
Neonatal Death (%) .35 1.9 4.9 
The Fetal and Neonatal Burden of Plurality 
Practice Committee of American Society for Reproductive Medicine. Fertil Steril April 2012. 
Linked Birth / Infant Death Records 2007-2010 on CDC WONDER On-line Database. Accessed at http://wonder.cdc.gov/lbd-current.html  
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Improving Controlled Ovarian Stimulation:  
Recommended Prudent Practice Patterns 
 American Society for Reproductive Medicine (ASRM) 
recommendations 
 Use of low-dose gonadotropin regimens 
 Use of Clomiphene  
 Use of Letrozole (Off-label) 
 Reduced birth plurality rates 
 Comparable per cycle pregnancy rates 
Practice Committee of American Society for Reproductive Medicine, Fertil Steril April 2012. 
Legro RS, N Engl J Med 2014. 
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Moving Towards Single Embryo Transfers 
 Improvements in Embryo Selection 
 Pre-implantation Genetic Screening (PGS) 
 Normal chromosomes or euploidy 
 Considered invasive 
 Embryonic division analysis or morphokinetics 
 Assessing embryonic cellular fission  




An “IVF-Dominant” Future? 
 A more direct path (“fast track”) to IVF 
 Without antecedent controlled ovarian stimulation 
 With a focus on Single Embryo Transfers 
 
 Limited Use of Controlled Ovarian Stimulation 
 
 Indicated Ovulation Induction 
28 
What the “BESST” Future Should Look Like  
 Infertility treatments resulting in fewer higher order  
     (twins or greater) births 
   
 Mothers receiving treatments face fewer medical risks 
 
 Neonates and infants born to mothers receiving recommended 
procedures also have a better prognosis 
 
 Alignment of the goals of clinical medicine with the goals of 
public health  
BESST: Birth Emphasizing a Successful Singleton at Term 
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Infertility from Both  
Male and Female Patients’ Perspective 
Barbara Collura 
President/CEO 
RESOLVE: The National Infertility Association 
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The Profound Impact of the  
Diagnosis of Infertility 
“For years I struggled with infertility. 
The physical and emotional toll of 
infertility, the monthly hope then 
heartbreak, the appointments with 
doctors and specialists, the shame 
and sadness, impacted our lives in 
ways big and small.  
 
I lost count of how many times I 
cried and prayed, beseeching God 
to ‘fix’ me so that Nate and I could 
be parents.   
 
For months, I felt broken and alone.” 
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The Profound Impact of the  
Diagnosis of Infertility 
“I was feeling sad, and hopeless and 
the 3 ½ years of trying, miscarriages 
and IVF had really taken its toll. I had 
even told my husband that I was ready 
to stop trying all together.   
 
Infertility is so lonely and isolating.” 
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Providing Support through the Journey 
 RESOLVE Support Groups 
 Each month, 194 peer-led support groups in 42 states 
 
 Blogs and Social Media 
 3,100 blogs on infertility, adoption, and pregnancy loss 
 People use social media to connect and get support 
 
 Meeting the growing needs of the infertility community 
 25th Anniversary of National Infertility Awareness Week 
  April 20-26, 2014 






Public Awareness About Infertility 
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Infertility Treatment and Insurance Coverage 
 Infertility is a disease, diagnosed by a physician  
 
 Most insurance plans, including Medicare and Medicaid, do 
not offer coverage, especially for IVF 
 Pre-requisites vary from plan to plan 
 
 Affordable Care Act may not expand coverage for  




Insurance Coverage at the State Level 
 Only 8 states have 
an IVF insurance 
mandate 
 AR, CT, HI, IL, 




 Another 7 states 
mandate coverage 
for some infertility 
treatment but do 
not cover IVF 
 CA, LA, MT, NY, 
OH, TX, WV 
 
 
 Pre-requisites vary from state to state 
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Impact of Lack of Insurance  
Coverage on Decision-Making  
 Out-of-pocket costs can be substantial and impact  patient 
     decision-making and risk-taking 
 Less effective treatments are pursued to lower costs  
 Precious time is wasted 
 Risks are ignored  
 Decisions not based on “best medical advice” 
 Maximize “return on investment” 
 Twins are perceived to be “less costly” 
     Non-ART: $200-$5,000         IVF: $10,000-$15,000 
    
Pollack, A NYTimes July 11, 2014. 
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Dealing with Infertility Shouldn’t  
Have to Be a Life Crisis 
 Access to emotional support and a sense of community can be 
life-changing 
 
 Patients who receive education and information have increased 
awareness and manage better 
 
 The current state of insurance coverage for infertility treatment 
can create incentives that lead to poor outcomes for both 
individual patients and for public health 
 Inequities in who gets care and who does not 
 Increased adverse health outcomes for mother and baby 
 
 The ASRM and SART standard of care should determine 
insurance coverage 
ASRM: American Society for Reproductive Medicine 
SART: Society for Assisted Reproductive Technology 
38 
Infertility Treatments  
from a Public Health Perspective 
Dmitry Kissin, MD, MPH 
Team Lead, Assisted Reproductive Technology Surveillance  
and Research Team, Division of Reproductive Health 
National Center for Chronic Disease Prevention and Health Promotion 
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ART: Assisted Reproductive Technology 




























Public Health Surveillance for ART 
 1981:  First ART-conceived infant born in 
the United States 
 
 1992:  U.S. Congress passed the Fertility 
Clinic Success Rate and Certification Act  
 
 1995:  CDC initiated National  
     ART Surveillance 
 
 All ART cycles are reported; non-ART 
fertility treatments are not reportable 























1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
ART-Conceived Infants, United States, 1996-2012 



























1.5% of all infants born in the 
U.S. are conceived with ART 
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Poor Perinatal Outcomes Associated  
with ART-conceived Infants, 2010 
 













Multiple birth infants Preterm (<37 weeks
gestation)
Low birth weight (<2500 g)
ART infants All infants
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Good Perinatal Outcomes Associated  


















Singleton birth infants Term (≥37 weeks) Normal birth weight (≥2500g)
One embryo transferred Two embryos transferred
National ART Surveillance System, 2010; http://www.cdc.gov/art/NASS.htm. 
Good Perinatal Outcome – term, normal birth weight singleton 
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Increased Use of ART and Single Embryo 
Transfers with Insurance Coverage, 2011 
National Vital Statistics System, 2011; http://www.cdc.gov/nchs/nvss.htm. 
















Percentage of ART infants among all
infants born
Percentage of Single Embryo
Transfers among all ART transfer
procedures
Mandate to cover ART
No mandate to cover ART
45 
ART Practice Guidelines and  
Good Perinatal Outcomes 
 Issued by American Society for Reproductive Medicine (ASRM) and 
Society for Assisted Reproductive Technology (SART) since 1998 
 
 Recommend maximum number of embryos to transfer during ART 
 
 Contributed to the reduction of  number of embryos transferred 
and number of triplets and higher order multiple births 
 






































Single Double 3 or more
Single, Double and Three or More Embryo 
Transfers, United States, 1997-2011 
Kulkarni AD, N Engl J Med 2013. 
All tests for trend P<0.001 
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Insurance Coverage and Practice Standards 
 Insurance coverage  
 Increased use of ART 
 Increased the percentage of elective single embryo transfers, but 
only 1 in 5 chose single embryo transfer, even with coverage  
 
 Practice Guidelines  
 Reduced the number of three or more embryos transferred  
 Have not reduced the number of twin gestations 
 
 Other countries have been able to successfully implement the 
restrictions on the number of embryos to transfer  by offering 
insurance coverage 
National Vital Statistics System, 2011; http://www.cdc.gov/nchs/nvss.htm. 
National ART Surveillance System, 2011; http://www.cdc.gov/art/NASS.htm. 
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Single Embryo Transfer (SET) 



































80% Australia and NZ Sweden Belgium United States
Year 
Chambers, Med J Aust 2011.  De Neubourg, Hum Reprod 2013. Karlström, Hum Reprod 2007. 
Information from National ART Surveillance Systems in Belgium, Sweden, United States, Australia and New Zealand, including 
unpublished data. 
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ART-Related Multiple Births  
in the United States and Other Countries 
Chambers, Med J Aust 2011.  De Neubourg, Hum Reprod 2013. Karlström, Hum Reprod 2007. 









































60% Australia and NZ Sweden Belgium United States
Year 
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Infertility, Infertility Treatments,  





Infertility, Infertility Treatments,  


















and Occupational  
Exposures 
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Centers for Disease Control and Prevention. National Public Health Action Plan for the Detection, Prevention, and Management of Infertility, July 2014. 
Available at  http://www.cdc.gov/reproductivehealth/Infertility/PublicHealth.htm 
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National Public Health Action Plan 
 Public health strategies can 
 
 Promote healthy behaviors to 
preserve fertility 
 
 Emphasize the prevention and  
    treatment of medical conditions 







 Reduce exposures to hazardous agents that affect fertility 
 







Detection of Infertility: 
Public Health Opportunities 
 Develop standardized case definitions 
 
 Improve surveillance for infertility and related factors 
 Enhance information collected in existing surveillance systems 
 Expand surveillance efforts 
 Collect information about  
    non-ART use and outcomes 
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Prevention of Infertility: 
Public Health Opportunities 
 Improved understanding of the risks and causes of infertility 
 Infectious diseases 
 Chronic conditions and diseases 
 Environmental/Workplace  
 Medication-induced 
 Modifiable behavioral factors 
 Genetic and physical  
    abnormalities 
 Increase public awareness of  
     causes of infertility and the  
     importance of prevention 
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Management of Infertility: 
Public Health Opportunities 
 Monitor safety and effectiveness of infertility treatments 
 ART: long-term outcomes unknown 
 Non-ART: short-term and long-term outcomes unknown 
 Promote evidence-based guidelines and recommendations 
 Increase public awareness of and eliminate disparities in 





In the End, It’s About Families 
E-mail questions, comments  
or concerns to: 
 drhinfo@cdc.gov 
National Public Health Action Plan for the Detection, Prevention, and Management  
of Infertility, July 2014. Available at: 
http://www.cdc.gov/reproductivehealth/Infertility/PublicHealth.htm 
